Published in Gene Therapy Weekly, October 30th, 2003
"The Tag-It CF40 Mutation Detection Kit, with an industry leading ability to identify the 40 most common genetic mutations in the CF gene, combines broad mutation coverage with unmatched speed, accuracy and cost," said Greg Hines, president and chief executive officer of Tm Bioscience.
"We expect the CF40 test to be our flagship product for the next several years as this market continues to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.